Robin Saltzman

1.8k total citations
18 papers, 1.4k citations indexed

About

Robin Saltzman is a scholar working on Epidemiology, Immunology and Oncology. According to data from OpenAlex, Robin Saltzman has authored 18 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 6 papers in Immunology and 5 papers in Oncology. Recurrent topics in Robin Saltzman's work include Cytomegalovirus and herpesvirus research (14 papers), Herpesvirus Infections and Treatments (10 papers) and Viral-associated cancers and disorders (5 papers). Robin Saltzman is often cited by papers focused on Cytomegalovirus and herpesvirus research (14 papers), Herpesvirus Infections and Treatments (10 papers) and Viral-associated cancers and disorders (5 papers). Robin Saltzman collaborates with scholars based in United States, United Kingdom and Sweden. Robin Saltzman's co-authors include Ron Boon, Phillip K. Peterson, Mary Quirk, M C Jordan, Rick A. Barbarash, Stephen K. Tyring, Terry M. Jones, Anthony L. Cunningham, John Marley and Madalene C.Y. Heng and has published in prestigious journals such as Journal of Clinical Investigation, Annals of Internal Medicine and Clinical Infectious Diseases.

In The Last Decade

Robin Saltzman

18 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robin Saltzman United States 15 1.1k 242 198 181 169 18 1.4k
A. P. Fiddian United Kingdom 21 1.2k 1.0× 423 1.7× 289 1.5× 131 0.7× 184 1.1× 34 1.5k
H H Balfour United States 16 801 0.7× 244 1.0× 141 0.7× 143 0.8× 100 0.6× 20 1.1k
Anne‐Marie Fillet France 22 968 0.8× 241 1.0× 69 0.3× 176 1.0× 255 1.5× 57 1.5k
Atsuko Hata Japan 16 881 0.8× 199 0.8× 126 0.6× 126 0.7× 246 1.5× 42 1.2k
David F. Busch United States 16 1.2k 1.0× 417 1.7× 27 0.1× 106 0.6× 170 1.0× 24 1.5k
Karlis Pauksens Sweden 23 964 0.8× 385 1.6× 45 0.2× 240 1.3× 249 1.5× 47 1.6k
Mindell Seidlin United States 21 661 0.6× 653 2.7× 56 0.3× 75 0.4× 102 0.6× 31 1.4k
Örjan Strannegård Sweden 23 407 0.4× 404 1.7× 127 0.6× 409 2.3× 102 0.6× 54 1.5k
Greet J. Boland Netherlands 20 862 0.8× 236 1.0× 238 1.2× 380 2.1× 84 0.5× 64 1.5k
Rupert Vessey United States 17 428 0.4× 117 0.5× 65 0.3× 416 2.3× 79 0.5× 20 1.5k

Countries citing papers authored by Robin Saltzman

Since Specialization
Citations

This map shows the geographic impact of Robin Saltzman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Saltzman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Saltzman more than expected).

Fields of papers citing papers by Robin Saltzman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin Saltzman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Saltzman. The network helps show where Robin Saltzman may publish in the future.

Co-authorship network of co-authors of Robin Saltzman

This figure shows the co-authorship network connecting the top 25 collaborators of Robin Saltzman. A scholar is included among the top collaborators of Robin Saltzman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin Saltzman. Robin Saltzman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Sarisky, Robert T., T. H. Bacon, Ron Boon, et al.. (2003). Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials. Archives of Virology. 148(9). 1757–1769. 35 indexed citations
2.
Sarisky, Robert T., Teresa H. Bacon, Ron Boon, et al.. (2002). Penciclovir Susceptibilities of Herpes Simplex Virus Isolates from Patients Using Penciclovir Cream for Treatment of Recurrent Herpes Labialis. Antimicrobial Agents and Chemotherapy. 46(9). 2848–2853. 14 indexed citations
3.
Tyring, Stephen K., Robert Bélanger, W. R. Bezwoda, et al.. (2001). A Randomized, Double-Blind Trial of Famciclovir Versus Acyclovir for the Treatment of Localized Dermatomal Herpes Zoster in Immunocompromised Patients. Cancer Investigation. 19(1). 13–22. 53 indexed citations
4.
Romanowski, Barbara, et al.. (2000). Efficacy and safety of famciclovir for treating mucocutaneous herpes simplex infection in HIV-infected individuals. AIDS. 14(9). 1211–1217. 41 indexed citations
5.
Schacker, Timothy W., David M. Koelle, Judith E. Zeh, et al.. (1998). Famciclovir for the Suppression of Symptomatic and Asymptomatic Herpes Simplex Virus Reactivation in HIV-Infected Persons: A Double-Blind, Placebo-Controlled Trial. Annals of Internal Medicine. 128(1). 21–28. 124 indexed citations
6.
Spruance, Spotswood L., et al.. (1997). Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group.. PubMed. 277(17). 1374–9. 140 indexed citations
7.
Saltzman, Robin & Ron Boon. (1995). The safety of famciclovir in patients with herpes zoster. Current Therapeutic Research. 56(3). 219–225. 3 indexed citations
8.
Tyring, Stephen K., Rick A. Barbarash, Anthony L. Cunningham, et al.. (1995). Famciclovir for the Treatment of Acute Herpes Zoster: Effects on Acute Disease and Postherpetic Neuralgia: A Randomized, Double-Blind, Placebo-Controlled Trial. Annals of Internal Medicine. 123(2). 89–96. 346 indexed citations
9.
Saltzman, Robin, et al.. (1994). Safety of famciclovir in patients with herpes zoster and genital herpes. Antimicrobial Agents and Chemotherapy. 38(10). 2454–2457. 79 indexed citations
10.
Jordan, M. Colin, et al.. (1993). Recurrent Kaposi's sarcoma in a renal transplant recipient: Regression following treatment of cytomegaloviremia with ganciclovir. Clinical Transplantation. 7(5). 491–495. 3 indexed citations
11.
Saltzman, Robin, Mary Quirk, & M C Jordan. (1992). High levels of circulating cytomegalovirus DNA reflect visceral organ disease in viremic immunosuppressed patients other than marrow recipients.. Journal of Clinical Investigation. 90(5). 1832–1838. 74 indexed citations
12.
Steeper, Theresa A., Charles A. Horwitz, Dharam V. Ablashi, et al.. (1990). The Spectrum of Clinical and Laboratory Findings Resulting from Human Herpesvirus-6 (HHV-6) in Patients with Mononucleosis-Like Illnesses not Resulting from Epstein-Barr Virus or Cytomegalovirus. American Journal of Clinical Pathology. 93(6). 776–783. 101 indexed citations
13.
Saltzman, Robin, Mary Quirk, Cary N. Mariash, & M. Colin Jordan. (1990). Quantitation of cytomegalovirus DNA by blot hybridization in blood leukocytes of viremic patients. Journal of Virological Methods. 30(1). 67–77. 18 indexed citations
14.
Saltzman, Robin & M C Jordan. (1989). Cytomegalovirus infections. Current Opinion in Infectious Diseases. 2(2). 262–266. 1 indexed citations
15.
Saltzman, Robin, Mary Quirk, & M C Jordan. (1988). Disseminated cytomegalovirus infection. Molecular analysis of virus and leukocyte interactions in viremia.. Journal of Clinical Investigation. 81(1). 75–81. 108 indexed citations
16.
Saltzman, Robin, Mary Quirk, & M. Colin Jordan. (1988). Molecular Analysis of Virus and Leukocyte Interactions in Viremia. 14 indexed citations
17.
Saltzman, Robin & Phillip K. Peterson. (1987). Immunodeficiency of the Elderly. Clinical Infectious Diseases. 9(6). 1127–1139. 171 indexed citations
18.
Saltzman, Robin, et al.. (1987). Interactions of human cytomegalovirus with leukocytes in vivo: analysis by in situ hybridization. Microbial Pathogenesis. 3(4). 287–297. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. P. Fiddian Breakdown of academic impact, for papers by H H Balfour Breakdown of academic impact, for papers by Anne‐Marie Fillet Breakdown of academic impact, for papers by Atsuko Hata Breakdown of academic impact, for papers by David F. Busch Breakdown of academic impact, for papers by Karlis Pauksens Breakdown of academic impact, for papers by Mindell Seidlin Breakdown of academic impact, for papers by Örjan Strannegård Breakdown of academic impact, for papers by Greet J. Boland Breakdown of academic impact, for papers by Rupert Vessey
Rankless by CCL
2026